DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer

被引：0

作者：

Varun Sasidharan Nair

Salman M. Toor

Rowaida Z. Taha

Hibah Shaath

Eyad Elkord

机构：

[1] Qatar Foundation,Cancer Research Center, Qatar Biomedical Research Institute, College of Science and Engineering, Hamad Bin Khalifa University

[2] Institute of Cancer Sciences,undefined

[3] University of Manchester,undefined

来源：

Clinical Epigenetics | 2018年 / 10卷

关键词：

Colorectal cancer; Immune checkpoints; PD-L1; Galectin-9; DNA methylation; Histone trimethylation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
Nair, Varun Sasidharan
Toor, Salman M.
Taha, Rowaida Z.
Shaath, Hibah
Elkord, Eyad
CLINICAL EPIGENETICS, 2017, 10
[2] DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
Varun Sasidharan Nair
Haytham El Salhat
Rowaida Z. Taha
Anne John
Bassam R. Ali
Eyad Elkord
Clinical Epigenetics, 2018, 10
[3] DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
Nair, Varun Sasidharan
El Salhat, Haytham
Taha, Rowaida Z.
John, Anne
Ali, Bassam R.
Elkord, Eyad
CLINICAL EPIGENETICS, 2018, 10
[4] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
Saleh, Reem
Toor, Salman M.
Khalaf, Sarah
Elkord, Eyad
VACCINES, 2019, 7 (04)
[5] Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study
Shi, Xiao
Li, Cui-Wei
Tan, Li-Cheng
Wen, Shi-Shuai
Liao, Tian
Zhang, Yan
Chen, Tong-Zhen
Ma, Ben
Yu, Peng-Cheng
Lu, Zhong-Wu
Qu, Ning
Wang, Yu
Shi, Rong-Liang
Wang, Yu-Long
Ji, Qing-Hai
Wei, Wen-Jun
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01): : 120 - 132
[6] Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma
Malinga, Nonkululeko Z.
Siwele, Shalete C.
Steel, Helen C.
Kwofie, Luyanda L., I
Meyer, Pieter W. A.
Smit, Teresa
Anderson, Ronald
Rapoport, Bernardo L.
Kgokolo, Mahlatse C. M.
TRANSLATIONAL ONCOLOGY, 2022, 19
[7] CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma
de Vos, Luka
Cano, Tzaitel Maria Carrillo
Zarbl, Romina
Kluemper, Niklas
Ralser, Damian Johannes
Franzen, Alina
Herr, Emmanuelle
Gabrielpillai, Jennis
Vogt, Timo Jakob
Dietrich, Joern
Strieth, Sebastian
Landsberg, Jennifer
Dietrich, Dimo
JOURNAL OF IMMUNOTHERAPY, 2022, 45 (07) : 324 - 334
[8] Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1, and TIM-3 are markedly increased in basal cell carcinoma
Rapoport, Bernardo Leon
Malinga, Nonkululeko
Siwele, Shalete
Steel, Helen C.
Kwofie, Luyanda Li
Meyer, Pieter
Smit, Teresa
Anderson, Ronald
Kgokolo, Mahlatse
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[9] Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study
Jin, Shengming
Shang, Zhi
Wang, Wenwen
Gu, Chengyuan
Wei, Yu
Zhu, Yu
Yang, Chen
Zhang, Tiantian
Zhu, Yao
Zhu, Yiping
Wu, Junlong
Ye, Dingwei
JOURNAL OF IMMUNOTHERAPY, 2023, 46 (04) : 154 - 159
[10] PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors
Wang, Jaeyun Jane
Burger, Peter
Taube, Janis
Soni, Abha
Chaichana, Kaisorn
Sheu, Mary
Belcaid, Zineb
Jackson, Christopher
Lim, Michael
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)

← 1 2 3 4 5 →